OGT Licenses Patents to Biotype Diagnostics for Microarray Technology Development

According to Biotype's executive director, the patents will help the company "develop our own microarray technology platform for various applications in medicine and analytics."

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.